Blumenthal seeks FTC pharma probe

Washington, D.C. (June 19, 2018) -- Senator Richard Blumenthal wants the Federal Trade Commission to investigate whether some drug companies are illegally withholding samples of brand-name drugs from generic manufacturers, driving up prices and limiting patient access to life-saving medications....

Related Sections